A Quarter-Billion Infections Annually

The single standard treatment for Trichomonas vaginalis is now in question

A recently published paper issues a challenge to the health and scientific community:

“Despite drug resistance being documented for decades, 5-Nitroimidazoles remain the only treatment option"

“Trichomoniasis is the most common, non-viral sexually transmitted infection worldwide, accounting for Quarter billion cases each year”

Read More ►


Key Facts*

While parasite colonization is inhibited by protective lactobacilli in the vaginal microbiota, T. vaginalis and the bacteria causing bacterial vaginosis amplify disease synergistically.

5-Nitromidazole treatment of trichomoniasis neither eliminates Mycoplasma nor counteracts the vaginal microbiome disturbances; hence novel therapies are necessary.

Metabolic interactions with Mycoplasma enhance the growth and weaken the macrophage-mediated killing of T. vaginalis.

* Trichomonas vaginalis Aquino, Marina Ferrari Klemm de et al. Trends in Parasitology, DOI


Improved diagnostics and larger clinical interventional studies
are needed to confirm the causative role of the parasite and infection.
  • Adverse reproductive outcomes including miscarriage and pre-term birth
  • Susceptibility to viral infections such as HIV
  • Cervical cancer


Card image cap
Biomed Diagnostics is committed to overcoming this disease

InPouch® TV is a cost-effective, easy to use, broth media device for combined collection, incubation, and detection.

Biomed's Diagnostics' Gold Standard media for T. vaginalis within InPouch TV is formulated for specificity — inhibiting the growth of yeasts, molds, bacteria and other micro-flora.

Request a Sample ►